Therefore, suppression of hepatic Rspo3 is associated with obesity-induced insulin resistance, systemically, as well as diabetes and changes in body compositions including the distributions of adipose tissue and skeletal muscle. The gene discussed is RSPO3; the disease is obesity due to melanocortin 4 receptor deficiency.